These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23943177)

  • 1. Role for a resident representative on a regional conference steering committee.
    Huber MR; Bookstaver PB; Darling C; Walker MC; Gregory DF
    Am J Health Syst Pharm; 2013 Sep; 70(17):1478-9. PubMed ID: 23943177
    [No Abstract]   [Full Text] [Related]  

  • 2. Partnering with a state pharmacy society to develop and implement a statewide residency conference.
    Dagam JK; Grzendzielewski CR; Sorum S
    Am J Health Syst Pharm; 2020 May; 77(10):728-729. PubMed ID: 32253438
    [No Abstract]   [Full Text] [Related]  

  • 3. The evolving role of the P&T committee: enhancing the health technology assessment process.
    Tadlock C
    Manag Care Interface; 2006 Feb; 19(2):14-5. PubMed ID: 16529077
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pharmacological committee yesterday, today and tomorrow].
    Lepakhin VK
    Ter Arkh; 1990; 62(9):4-7. PubMed ID: 2281404
    [No Abstract]   [Full Text] [Related]  

  • 5. Incorporation of formal leadership activities into pharmacy residencies.
    Saito EM; Patel RJ; Herrera EM; Kroner BA
    Am J Health Syst Pharm; 2017 Feb; 74(4):196-199. PubMed ID: 28179244
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacy leadership development through national resident collaboration.
    Wolf M; Smith J; Proctor C
    Am J Health Syst Pharm; 2016 Mar; 73(5):268-9. PubMed ID: 26896496
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The investigational drug steering committee.
    Ratain MJ
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):779-80. PubMed ID: 17998895
    [No Abstract]   [Full Text] [Related]  

  • 9. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Second edition of the CoBioMe congress].
    Janot C; Lefrère B; Michel M; Le Guillou E; Schell B
    Ann Biol Clin (Paris); 2019 Apr; 77(2):233-240. PubMed ID: 30998203
    [No Abstract]   [Full Text] [Related]  

  • 11. ASHP statement on the pharmacy and therapeutics committee.
    Am J Hosp Pharm; 1986 Nov; 43(11):2841-2. PubMed ID: 3799625
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monitoring of clinical trials and interim analysis. 1. Monitoring committee].
    Boutitie F; Bellissant E; Blanchard J; Boissel JP; Cauquil J; Chauvin F; Derzko G; Ducruet T; Durrleman S; Girre JP
    Therapie; 1992; 47(4):345-9. PubMed ID: 1494799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy and therapeutics committee review of the parenteral cephalosporins.
    Phelps MR; Godwin HN
    Am J Hosp Pharm; 1978 Jan; 35(1):73-5. PubMed ID: 623122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy and therapeutics committee 'virtual' meetings.
    Devenport C
    Am J Health Syst Pharm; 1999 Jun; 56(11):1132. PubMed ID: 10385462
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines on the operation of the pharmacy and therapeutics committee and formulary.
    Linkewich JA; Prevoznik SJ
    Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149
    [No Abstract]   [Full Text] [Related]  

  • 16. Individualization of resident orientation for nontraditional pharmacy residents.
    Crannage AJ; Pitlick JM; Burke JM
    Am J Health Syst Pharm; 2016 Apr; 73(7):433-4. PubMed ID: 27001982
    [No Abstract]   [Full Text] [Related]  

  • 17. Report of the AACP Special Committee on Substance Abuse and Pharmacy Education.
    Jungnickel PW; Desimone EM; Kissack JC; Lawson LA; Murawski MM; Patterson BJ; Rospond RM; Scott DM; Athay J;
    Am J Pharm Educ; 2010 Dec; 74(10):S11. PubMed ID: 21436899
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic review: the experience of one pharmacy and therapeutics committee.
    Kiepert DR
    QRB Qual Rev Bull; 1979 Jan; 5(1):24-7. PubMed ID: 121376
    [No Abstract]   [Full Text] [Related]  

  • 19. In what ways does the pharmacy department actively participate in P & T Committee meetings?
    Wooten JM; Williams R; Merryfield D
    Hosp Formul; 1990 Nov; 25(11):1186. PubMed ID: 10107822
    [No Abstract]   [Full Text] [Related]  

  • 20. Reassessing pharmacy and therapeutics committees.
    Stolar MH
    Am J Hosp Pharm; 1984 Aug; 41(8):1527. PubMed ID: 6475972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.